Related Experiment Video
Updated: May 17, 2026
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013
Kenneth C Anderson1, Melissa Alsina, William Bensinger
1Dana-Farber/Brigham and Women's Cancer Center.
Journal of the National Comprehensive Cancer Network : JNCCN
|October 12, 2012
Abstract:
These NCCN Guidelines Insights highlight the important updates/changes specific to the management of Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma. These include the addition of regimens containing novel agents as primary and salvage therapy options, inclusion of the updated summary of response categories and criteria from the sixth international workshop on Waldenström's Macroglobulinemia, and a section on management of peripheral neuropathy in the accompanying discussion.
